Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-15

Clinical Trial Update: Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on alefacept in chronic plaque psoriasis patients who failed anti-TNF therapy; the study was terminated and results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alefacept (Alefacept)

Snippet

Sponsor: John Murray | Conditions: Chronic Plaque Psoriasis | Phase 4 | Status: TERMINATED | Results posted: 2013-02-15